OvuSense (Fertility Focus)

Name

OvuSense (Fertility Focus)

Legal name

viO HealthTech Inc

Website

https://ovusense.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Medical Devices – Fertility Monitoring

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices) (CRACAQAJ)

akta.pro secondary industry

Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG)

Keywords

• Fertility monitoring devices
• Ovulation tracking sensors
• PCOS cycle tracking
• Digital women's health
• Medical device subscription

Headquarters

HQ city

Warwick

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Hardware Sales - Sensors: One-time purchase of OvuCore vaginal sensor (£79 UK, similar pricing regionally) or OvuFirst skin sensor (£39 UK). Sensors have 365-day lifespan from first registration. Includes starter pack with sensor and initial subscription period.
2. Standard Subscription: Monthly recurring subscription (£20/month UK, €25/month Europe, AU$40/month Australia) required to download and process sensor data to app. Annual subscriptions available at discounted rates (£120/year UK, €165/year Europe, AU$249/year Australia). Includes cycle tracking, ovulation prediction and confirmation, fertile window identification.
3. OvuSense Pro Subscription: Premium tier (£25/month UK, €29/month Europe, AU$45/month Australia) adds advanced cycle pattern analysis, treatment and medication tracking, remote monitoring for doctor. Requires active Standard subscription. Includes automatic flagging of atypical cycle patterns for clinical diagnosis.
4. Affiliate Program: Partners earn commission on product sales directed from their referral links. Minimum sales levels apply. Targeted at fertility influencers and content creators.

Pricing tiers

Go-to-market motion2 records

Distribution channels6 records

Marketing channels6 records

Core offering

OvuSense sells FDA-cleared Class II medical-device fertility monitors: the OvuCore vaginal sensor (£79) and OvuFirst skin sensor (£39) take overnight continuous Core Body Temperature (cCBT) measurements at 0.003°C resolution and transmit via NFC to a companion app that predicts and confirms ovulation. Revenue is generated through a one-time hardware purchase plus a required monthly (£20/mo UK) or annual subscription for app data processing, with an OvuSense Pro upgrade tier (£25/mo UK) that adds clinician-facing cycle pattern analysis, treatment tracking, and remote monitoring.

Product overview

OvuSense is a fertility and ovulation monitoring system consisting of two proprietary sensors (OvuCore vaginal sensor and OvuFirst skin sensor), a mobile app, and an optional OvuSense Pro clinician portal. OvuCore is the primary product, measuring continuous Core Body Temperature (cCBT) internally with 0.003°C resolution. OvuFirst offers a skin-based alternative using the same thermistor technology. Both sensors connect via NFC to the OvuSense App, which uses patented algorithms to predict ovulation in real-time and confirm ovulation with 99% accuracy. The optional OvuSense Pro subscription adds advanced cycle pattern analysis with automatic flagging of eight unique cycle patterns for clinical diagnosis. The system is designed for women trying to conceive, particularly those with irregular cycles or PCOS, and for clinicians monitoring fertility treatment.

Differentiator

Problem solved

Functional benefit

Products and services

• OvuCore Sensor Vaginal temperature sensor approximately the size of a tampon, worn overnight to capture continuous Core Body Temperature measurements every 5 minutes using a 0.003°C-resolution thermistor. Transmit data to the OvuSense app via NFC; confirms ovulation with 99% accuracy and predicts ovulation in real time with 96% positive predictive value. 12-month battery life. For women trying to conceive, including those with irregular cycles or PCOS.
• OvuFirst Sensor Skin-worn temperature sensor that attaches to the wrist via wristband or under the armpit via armband and takes overnight continuous skin temperature readings using identical 0.003°C-resolution thermistor components to OvuCore. Confirms the ovulation window with over 90% accuracy. Designed for users who prefer an external sensor over the internal OvuCore.
• OvuSense App Free mobile application for iOS and Android that receives sensor data via NFC, applies proprietary algorithms to predict and confirm ovulation, displays the fertile window, and identifies cycle patterns. Available in 10 languages: English, French, Danish, German, Spanish, Finnish, Italian, Dutch, Norwegian, Portuguese, Swedish. Required companion app for both OvuCore and OvuFirst sensors.
• OvuSense Pro Clinician Portal Clinician-facing portal providing in-depth cycle pattern analysis for medical professionals. Automatically flags eight unique cycle patterns (Early Ovulation, Late Ovulation, Anovulation, Short Luteal Phase, Slow Rise, Fall to Baseline, False Start, Fall after Ovulation) to aid diagnosis of PCOS, miscarriage risk, and pregnancy complications. Includes treatment and medication tracking. Requires a separate Pro subscription in addition to the Standard subscription.

Quantifiable outcome

• 99% accuracy confirming ovulation
• +6 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Six partnerships are on record, tiered core, regional and minor.

• StripecoreTechnology or IntegrationPayment processing gateway for all e-commerce transactions on company websites. Handles credit/debit card payments securely. Customers can also pay via PayPal account.
• Apple App StorecoreTechnology or IntegrationOvuSense app distributed through Apple App Store for iOS devices. Compatible with iPhone 7, X and later with NFC running iOS 8 or later.
• Google PlaycoreTechnology or IntegrationOvuSense app distributed through Google Play for Android devices with NFC capability. Not compatible with Samsung Ultra/Plus series, Huawei phones, or OnePlus Nord 2 5G.
• KD & A Pty LtdregionalImplementation/ SI/ Consulting PartnerAuthorized representative in Australia for regulatory compliance with TGA. Located at 286 Flinders Street, Adelaide, SA 5000, Australia.
• Royal MailminorOthersUK delivery partner for product shipments. Delivers in 2-3 working days via 1st Class Royal Mail.
• Fertility FocuscoreOthersOriginal company name and legal entity still referenced in certain contexts. Fertility Focus Limited registered in England and Wales No. 05546719. Parent company behind OvuSense brand.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Natural Cycles: Natural Cycles is an FDA-cleared fertility tracking app that uses basal body temperature measurement to identify fertile windows. Directly competes with OvuSense in the consumer fertility monitoring category, particularly for women seeking non-hormonal contraception or conception planning.
• Ava: Ava is a wearable fertility tracker bracelet that combines skin temperature, heart rate, HRV, and other physiological signals to predict fertile windows. Competes with OvuSense for women trying to conceive but uses multi-modal non-invasive wearable technology rather than cCBT.
• Mira: Mira provides at-home hormone testing (LH, E3G, PdG) via urine-based quantitative test strips and an analyzer for fertility tracking. Competes with OvuSense in the consumer fertility tracking space but takes a hormone-measurement approach rather than temperature-based ovulation detection.
• Tempdrop: Tempdrop is a wearable basal body temperature sensor worn on the upper arm overnight that uses an algorithm to identify fertile windows. Directly competes with OvuSense's OvuFirst sensor for women seeking continuous overnight temperature monitoring with a non-vaginal form factor.
• Daysy: Daysy is a smart fertility tracker that uses basal body temperature measurement to identify fertile and infertile days. Directly competes with OvuSense as a temperature-based fertility monitor targeting women seeking non-hormonal cycle tracking and conception planning.

Broad incumbents

• Clearblue: Clearblue is a major consumer brand offering pregnancy tests, ovulation test kits, and advanced fertility monitors. Competes with OvuSense in the OTC fertility tracking category but focuses on urine-based LH testing rather than continuous temperature monitoring.
• Oura: Oura is a smart ring that tracks temperature, sleep, HRV, and other biometrics. While not exclusively a fertility product, Oura's temperature trend tracking is increasingly used for cycle and fertility insights, making it an adjacent competitor in the consumer wearable fertility tracking space.

Emerging players

• iFertracker: iFertracker is a wearable oral temperature sensor that continuously measures temperature overnight to predict ovulation. Competes with OvuSense in the high-precision continuous temperature monitoring category but uses a sublingual rather than intravaginal sensor form factor.
• Femometer: Femometer offers a smart basal thermometer paired with a fertility tracking app for ovulation prediction. Competes with OvuSense in the consumer ovulation tracking space at a lower price point but with less clinical validation and accuracy.

Others

• Glow: Glow is a popular fertility and ovulation tracking app with optional integration with connected thermometers and wearables. Competes indirectly with OvuSense by capturing the mass-market fertility tracking audience, but is a software-first platform without proprietary hardware.

Market position

Strengths5 records

Weaknesses2 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/ovusense
• Facebookfacebook.com/ovusense

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds8 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OvuSense (Fertility Focus)